Nyasha Mafirakureva

All publications

Journal articles

• Mafirakureva N, Mukherjee S, de Souza M, Kelly-Cirino C, Songane MJP, Cohn J, Lemaire J-F, Casenghi M & Dodd PJ (2023) Cost-effectiveness analysis of interventions to improve diagnosis and preventive therapy for paediatric tuberculosis in 9 sub-Saharan African countries: A modelling study.. PLoS Med, 20(9), e1004285.
• Stone J, Fraser H, Walker JG, Mafirakureva N, Mundia B, Cleland C, Bartilol K, Musyoki H, Waruiru W, Ragi A , Bhattacharjee P et al (2022) Modelling the impact of HIV and hepatitis C virus prevention and treatment interventions among people who inject drugs in Kenya. AIDS, 36(15), 2191-2201.
• Mafirakureva N, Klinkenberg E, Spruijt I, Levy J, Shaweno D, de Haas P, Kaswandani N, Bedru A, Triasih R, Gebremichael M , Dodd PJ et al (2022) Xpert ultra stool testing to diagnose tuberculosis in children in Ethiopia and Indonesia: a model-based cost-effectiveness analysis. BMJ Open, 12(7). View this article in WRRO
• Dodd PJ, Mafirakureva N, Seddon JA & McQuaid CF (2022) The global impact of household contact management for children on multidrug-resistant and rifampicin-resistant tuberculosis cases, deaths, and health-system costs in 2019: a modelling study. The Lancet Global Health. View this article in WRRO
• Vasiliu A, Tiendrebeogo G, Awolu MM, Akatukwasa C, Tchakounte BY, Ssekyanzi B, Tchounga BK, Atwine D, Casenghi M, Bonnet M , Bonnet M et al (2022) Feasibility of a randomized clinical trial evaluating a community intervention for household tuberculosis child contact management in Cameroon and Uganda. Pilot and Feasibility Studies, 8. View this article in WRRO
• Ward Z, Mafirakureva N, Stone J, Keevans M, Betts-Symonds G, Crowley D, McHugh T, Avramovic G, Lambert JS & Vickerman P (2021) Cost-effectiveness of mass screening for Hepatitis C virus among all inmates in an Irish prison. International Journal of Drug Policy, 96. View this article in WRRO
• Mafirakureva N, Stone J, Fraser H, Nzomukunda Y, Maina A, Thiong'o AW, Kizito KW, Mucara EWK, González Diaz CI, Musyoki H , Mundia B et al (2021) An intensive model of care for hepatitis C virus screening and treatment with direct‐acting antivirals in people who inject drugs in Nairobi, Kenya : a model‐based cost‐effectiveness analysis. Addiction.
• Dzingirai B, Katsidzira L, Matyanga CMJ, Postma MJ, van Hulst M & Mafirakureva N (2021) Progress on the elimination of viral hepatitis in Zimbabwe: A review of the policies, strategies and challenges. Journal of Viral Hepatitis, 28(7), 994-1002. View this article in WRRO
• Marquez LK, Chaillon A, Soe KP, Johnson DC, Zosso J-M, Incerti A, Loarec A, Nguyen A, Walker JG, Mafirakureva N , Lo Re III V et al (2021) Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in Myanmar. BMJ Global Health, 6(2). View this article in WRRO
• Mafirakureva N, Lim AG, Khalid GG, Aslam K, Campbell L, Zahid H, Van den Bergh R, Falq G, Fortas C, Wailly Y , Auat R et al (2020) Cost‐effectiveness of screening and treatment using direct‐acting antivirals for chronic Hepatitis C virus in a primary care setting in Karachi, Pakistan. Journal of Viral Hepatitis.
• Walker JG, Mafirakureva N, Iwamoto M, Campbell L, Kim CS, Hastings RA, Doussett J, Le Paih M, Balkan S, Marquardt T , Maman D et al (2020) Cost and cost‐effectiveness of a simplified treatment model with direct‐acting antivirals for chronic hepatitis C in Cambodia. Liver International, 40(10), 2356-2366.
• Lim AG, Walker J, Mafirakureva N, Khalid GG, Qureshi H, Mahmood H, Trickey A, Fraser H, Aslam K, Falq G , Fortas C et al (2020) Modelling the cost of hepatitis C virus transmission in Pakistan. Journal of Hepatology, 73, S791-S791.
• Walker J, Mafirakureva N, Marquez L, Stone J, Lim AG, Campbell L, Khalid GG, Iwamoto M, Aslam K, Wailly Y , Zahid H et al (2020) Cost-effectiveness of screening and treatment using direct-acting antivirals for chronic hepatitis C virus in low- and middle-income settings. Journal of Hepatology, 73, S812-S813.
• Ward Z, Mafirakureva N, Stone J, Keevans M, Bett-Simmonds G, Crowley D, Mchugh T, Avramovic G, Lambert J & Vickerman P (2020) Cost-effectiveness of mass screening for HCV in an Irish prison. Journal of Hepatology, 73, S832-S832.
• Bivegete S, Ward Z, Walker J, Campbell L, Mafirakureva N, Swan D, O’connor E, McCombe G, Mchugh T, Crowley D , Kennedy M et al (2020) Comparison of costs of different HCV screening and linkage to care interventions across Europe. Journal of Hepatology, 73, S825-S825.
• Denoeud-Ndam L, Otieno-Masaba R, Tchounga B, Machekano R, Simo L, Mboya JP, Kose J, Tchendjou P, Bissek A-CZ-K, Okomo GO , Casenghi M et al (2020) Integrating pediatric TB services into child healthcare services in Africa: study protocol for the INPUT cluster-randomized stepped wedge trial. BMC Public Health, 20(1). View this article in WRRO
• Lim AG, Walker JG, Mafirakureva N, Khalid GG, Qureshi H, Mahmood H, Trickey A, Fraser H, Aslam K, Falq G , Fortas C et al (2020) Effects and cost of different strategies to eliminate hepatitis C virus transmission in Pakistan: a modelling analysis. The Lancet Global Health, 8(3), e440-e450. View this article in WRRO
• Gregson CL, Cassim B, Micklesfield LK, Lukhele M, Ferrand RA, Ward KA & SAMSON Collaborative Working Group (2019) Fragility fractures in sub-Saharan Africa : time to break the myth. The Lancet Global Health, 7(1), e26-e27. View this article in WRRO
• Mafirakureva N, Mapako T, Khoza S, Emmanuel JC, Marowa L, Mvere D, Postma MJ & van Hulst M (2016) Cost effectiveness of adding nucleic acid testing to hepatitis B, hepatitis C, and human immunodeficiency virus screening of blood donations in Zimbabwe. Transfusion, 56(12), 3101-3111.
• Mapako T, Mafirakureva N, Mutenherwa M, Bvuma G, Mvere DA, Marowa LM, Emmanuel JC & Bates I (2016) A systematic approach for reviewing research capacity within Zimbabwe's national blood service. ISBT Science Series, 11(2), 110-117.
• (2016) Erratum. Transfusion, 56(7), 1920-1920.
• Mafirakureva N, Nyoni H, Nkomo SZ, Jacob JS, Chikwereti R, Musekiwa Z, Khoza S, Mvere DA, Emmanuel JC, Postma MJ & van Hulst M (2016) The costs of producing a unit of blood in Zimbabwe. Transfusion, 56(3), 628-636.
• Mafirakureva N, Dzingirai B, Postma MJ, van Hulst M & Khoza S (2016) Health-related quality of life in HIV/AIDS patients on antiretroviral therapy at a tertiary care facility in Zimbabwe. AIDS Care, 28(7), 904-912.
• Mafirakureva N, Khoza S, Hassall O, Faragher BE, Kajja I, Mvere DA, Emmanuel JC, Postma MJ & Van Hulst M (2015) Profiles of blood and blood component transfusion recipients in Zimbabwe. Blood Transfusion, 13(4), 600-609.
• Mafirakureva N, Khoza S, Mvere DA, Chitiyo ME, Postma MJ & Van Hulst M (2014) Incidence and pattern of 12 years of reported transfusion adverse events in Zimbabwe: A retrospective analysis. Blood Transfusion, 12(3), 362-367.
• Pilla Reddy V, Kozielska M, Johnson M, Mafirakureva N, Vermeulen A, Liu J, de Greef R, Rujescu D, Groothuis GMM, Danhof M & Proost JH (2013) Population Pharmacokinetic-Pharmacodynamic Modeling of Haloperidol in Patients With Schizophrenia Using Positive and Negative Syndrome Rating Scale. Journal of Clinical Psychopharmacology, 33(6), 731-739.
• Hanbury A, Mafirakureva N, Chicken N & Bailey L () Evaluating change in a pressured healthcare system: a cross-sectional study of implementation outcomes using routine data indicators and proxies. Implementation Science Communications, 4(1).
• Burton A, Drew S, Cassim B, Jarjou LM, Gooberman-Hill R, Noble S, Mafirakureva N, Graham SM, Grundy C, Hawley S , Wilson H et al () Fractures in sub-Saharan Africa: epidemiology, economic impact and ethnography (Fractures-E3): study protocol. Wellcome Open Research, 8, 261-261.
• Mafirakureva N, Paruk F, Cassim B, Lukhele M, Gregson CL & Noble SM () The healthcare system costs of hip fracture care in South Africa. Osteoporosis International.
• McCombe G, Swan D, Lambert JS, O’Connor E, Ward Z, Vickerman P, Avramovic G, Crowley D, Tinago W, Mafirakureva N & Cullen W () Integrating Hepatitis C Care for Opioid Substitution Treatment Patients Attending General Practice: Feasibility, Clinical, and Cost-Effectiveness Analysis. Interactive Journal of Medical Research, 11(2), e35300-e35300.

Conference proceedings papers

• Mafirakureva N, Shoko P, Khoza S, Torpey K, Postma MJ & van Hulst M (2015) Assessment of the Costs and outcomes of Antiretroviral Therapy In Adult Outpatients at a Tertiary Hospital In Harare, Zimbabwe. Value in Health, Vol. 18(3) (pp A236-A236)
• Mafirakureva N, Nyoni H, Chikwereti R, Khoza S, Mvere DA, Emmanuel JC, Postma MJ & van Hulst M (2014) The Average Unit Production Cost of Blood in Zimbabwe from a Provider's Perspective. TRANSFUSION, Vol. 54 (pp 237A-237A)
• Mafirakureva N, Khoza S, van Hulst M, Postma MJ & Mvere DA (2013) THE EVALUATION OF BLOOD DONOR DEFERRAL CAUSES IN ZIMBABWE. VOX SANGUINIS, Vol. 105 (pp 97-97)

Preprints

• Stone J, Fraser H, Walker JG, Mafirakureva N, Mundia B, Cleland C, Kigen B, Musyoki H, Waruiru W, Ragi A , Bhattacharjee P et al () Modelling the Impact of Prevention and Treatment Interventions on HIV and Hepatitis C Virus Transmission Among People Who Inject Drugs in Kenya, Cold Spring Harbor Laboratory.